Patent ID: 8828399

Claim:
An antibody that specifically binds a cytomegalovirus (CMV) protein complex comprising pUL130 and a CMV protein selected from the group consisting of gH, gL, pUL128 and pUL131, said antibody is selected from the group consisting of: (a) an antibody secreted by hybridoma cell line ATCC Accession No. PTA-8472; (b) an antibody comprising a heavy chain of a monoclonal antibody secreted by hybridoma cell line ATCC Accession No. PTA-8472; (c) an antibody comprising a light chain of a monoclonal antibody secreted by hybridoma cell line ATCC Accession No. PTA-8472; (d) an antibody comprising the six CDRs from the heavy chain and the light chain of a monoclonal antibody secreted by hybridoma cell line ATCC Accession No. PTA-8472; (e) an antibody fragment comprising a heavy chain or a light chain of a monoclonal antibody secreted by hybridoma cell line ATCC Accession No. PTA-8472; and (f) an antibody fragment comprising the six CDRs from the heavy chain and the light chain of a monoclonal antibody secreted by hybridoma cell line ATCC Accession No. PTA-8472, wherein the antibody reduces CMV binding to a cell.